A 2022 study evaluating nine FDA-approved drugs for anti-aging potential ranked SGLT2 inhibitors highest, above metformin
Agree
Disagree
Overview
Debates
Related claims
Topics
Best
Space b5a31f
Loading debates…
Opening sign-in…